
Embryo Gene Editing: Why Altman’s Bet Alarms Watchers
Key Takeaways Preventive is a startup focused on using embryo gene editing to prevent hereditary diseases and has raised around $30 million from high-profile backers, including OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong. Heritable human genome editing (using genetically modified embryos to initiate a pregnancy) is effectively prohibited in the United States, the […]
Read the full story at The Unexplained Company...







